U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
HUMAN RHO(D) IMMUNE GLOBULIN
48W7181FLP
US Approved Rx (1998)
First approved in 1971
General
Record Details
Variant Concepts
3
Names
8
Classification
4
Identifiers
11
Relationships
3
Active Moiety
1
Modifications
1
HUMAN RHO(D) IMMUNE GLOBULIN
48W7181FLP
US Approved Rx (1998)
First approved in 1971
General
Approval Year
1971
86
Record Details
Substance Class
Structurally Diverse
Source Materials Class
ORGANISM
Source Materials Type
HUMAN
Source Materials Parent
G0T704E6Z3
HOMO SAPIENS WHOLE
Part
BLOOD
Fraction Name
PROTEIN IMMUNOGLOBULINS, IGG
Record UNII
48W7181FLP
Record Status
Validated (UNII)
Record Version
13
12
11
10
9
8
7
6
5
4
3
2
1
Show
5
20
100
All
entries
Related Record
Type
Related Record
Type
No data available in table
Showing 0 to 0 of 0 entries
Previous
Next
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
HUMAN RHO(D) IMMUNE GLOBULIN
Common Name
English
HUMAN ANTI-D IMMUNOGLOBULIN (IV)
Common Name
English
RHO D IMMUNE GLOBULIN HUMAN
Common Name
English
Anti-d immunoglobulin [WHO-DD]
Common Name
English
ANTI-D IMMUNOGLOBULIN
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Immunologicals
WHO ESSENTIAL MEDICINES LIST
Immunologicals
Sera and immunoglobulins
WHO-ESSENTIAL MEDICINES LIST
19.2
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Human Immunoglobulin G
[EPC]
NDF-RT
N0000184165
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of immune thrombocytopenic purpura.
FDA ORPHAN DRUG
74993
Immunotherapeutic Agent
Pharmacologic Substance
[C1909]
Immunotherapeutic Agent
[C308]
Therapeutic Immune Globulin
NCI_THESAURUS
C2701
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EVMPD
SUB12028MIG
PRIMARY
EVMPD
SUB127252
PRIMARY
DAILYMED
48W7181FLP
PRIMARY
FDA UNII
48W7181FLP
PRIMARY
NDF-RT
N0000184012
PRIMARY
Endogenous Antigen Neutralization [MoA]
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Relationships
3
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
RHO(D) IMMUNE GLOBULIN IM HUMAN
SUB_CONCEPT->SUBSTANCE
RHO(D) IMMUNE GLOBULIN HUMAN
SUB_CONCEPT->SUBSTANCE
RHO(D) IMMUNE GLOBULIN (HUMAN)
SUB_CONCEPT->SUBSTANCE
Showing 1 to 3 of 3 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
48W7181FLP
HUMAN RHO(D) IMMUNE GLOBULIN
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Modifications
1
Agent Modifications
Show
5
20
100
All
entries
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
TARGETED ANTIGEN
IMMUNOLOGICAL
BLOOD GROUP RH(D) POLYPEPTIDE
16YYC73841
Showing 1 to 1 of 1 entries
Previous
1
Next